Delaware's Incyte Corp. is in court this week seeking hundreds of millions of dollars from a former-Silicon Valley competitor.
The Wilmington pharmaceutical company argues in a lawsuit that its rival,
Flexus Biosciences, in 2014 stole trade secrets for a drug that at the
time was thought to have enormous potential for the treatment
of tumors.
During opening statements on Tuesday, Incyte attorney Steve Wood told
jurors that Flexus employed the services of "a spy and a sellout" to
steal information about blood tests and about how the drug metabolizes
in a patient's body. more
